![Bruce Trapp](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Bruce Trapp is the Chief Scientific Officer and founder of Renovo Neural, Inc. (founded in 2008).
Dr. Trapp is also the founder of Cashel Neural, Inc.
Aktive Positionen von Bruce Trapp
Unternehmen | Position | Beginn |
---|---|---|
Renovo Neural, Inc.
![]() Renovo Neural, Inc. BiotechnologyHealth Technology Renovo Neural, Inc. provides preclinical contract research services specializing in neuroscience. Its services include cell-based assays, MS animal models, PD animal models, three dimensional electron microscopy, standard and customized histology, preclinical magnetic resonance imaging, and image analysis. The company was founded by Bruce Trapp in 2008 and is headquartered in Cleveland, OH. | Gründer | 01.01.2008 |
Ehemalige bekannte Positionen von Bruce Trapp
Unternehmen | Position | Ende |
---|---|---|
Cashel Neural, Inc.
![]() Cashel Neural, Inc. BiotechnologyHealth Technology Cashel Neural, Inc. is a for-profit company that aims to develop and commercialize novel therapies for multiple sclerosis. The company is based in Cleveland, OH and was founded by Bruce Trapp, PhD, and Satish Medicetty, DVM, PhD, MBA. Cashel Neural's core technology is focused on developing small molecules that can promote remyelination by stimulating oligodendrocyte precursor cells to differentiate into mature oligodendrocytes and make new myelin. The company has received funding from the National Multiple Sclerosis Society's Fast Forward to support early-stage discovery and development. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Renovo Neural, Inc.
![]() Renovo Neural, Inc. BiotechnologyHealth Technology Renovo Neural, Inc. provides preclinical contract research services specializing in neuroscience. Its services include cell-based assays, MS animal models, PD animal models, three dimensional electron microscopy, standard and customized histology, preclinical magnetic resonance imaging, and image analysis. The company was founded by Bruce Trapp in 2008 and is headquartered in Cleveland, OH. | Health Technology |
Cashel Neural, Inc.
![]() Cashel Neural, Inc. BiotechnologyHealth Technology Cashel Neural, Inc. is a for-profit company that aims to develop and commercialize novel therapies for multiple sclerosis. The company is based in Cleveland, OH and was founded by Bruce Trapp, PhD, and Satish Medicetty, DVM, PhD, MBA. Cashel Neural's core technology is focused on developing small molecules that can promote remyelination by stimulating oligodendrocyte precursor cells to differentiate into mature oligodendrocytes and make new myelin. The company has received funding from the National Multiple Sclerosis Society's Fast Forward to support early-stage discovery and development. | Health Technology |